BINDU PAREKATTIL
Allopathic & Osteopathic Physicians|Pediatrics OCOEE, FL NPI 1346358355
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics FL Acerta Pharma LLC All categories
General Payments — all program years on this page
$937.44
- Category: General Payments
- Program years: PY2018–2024
- Record count: 45
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $179.91 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $179.91 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $34.46 | 1 |
| PFIZER INC. | $29.89 | 2 |
| GlaxoSmithKline, LLC. | $24.81 | 1 |
| Merck Sharp & Dohme Corporation | $24.54 | 1 |
| Verrica Pharmaceuticals Inc. | $24.10 | 1 |
| SANOFI-AVENTIS U.S. LLC | $14.40 | 1 |
| Phadia US Inc. | $13.98 | 1 |
| Tris Pharma Inc | $13.73 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1067576298 | Phadia US Inc. | $13.98 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105626963 | AstraZeneca Pharmaceuticals LP | $34.46 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116287696 | GlaxoSmithKline, LLC. | $24.81 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118382398 | Verrica Pharmaceuticals Inc. | $24.10 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131151732 | PFIZER INC. | $14.73 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131892047 | PFIZER INC. | $15.16 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139667758 | SANOFI-AVENTIS U.S. LLC | $14.40 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141976302 | Merck Sharp & Dohme LLC | $24.54 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147208305 | Tris Pharma Inc | $13.73 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.